-transparent.png){kind=logo}
This study demonstrated that exposure of cultured human aortic smooth muscle cells (SMC) to fluid flow resulted in nitric oxide (NO) production, monitored by nitrite and guanosine 3',5'-cyclic monophosphate production. A rapid burst in nitrite production rate was followed by a more gradual increase throughout the period of flow exposure. Neither the initial burst nor the prolonged nitrite production was dependent on the level of shear stress in the range of 1.1-25 dyn/cm2. Repeated exposure to shear stress after a 30-min static period restimulated nitrite production similar to the initial burst. Ca(2+)-calmodulin antagonists blocked the initial burst in nitrite release. An inhibitor of nitric oxide synthase (NOS) blocked nitrite production, indicating that changes in nitrite reflect NO production. Treatment with dexamethasone or cycloheximide had no effect on nitrite production. Monoclonal antibodies directed against the inducible and endothelial NOS isoforms showed no immunoreactivity on Western blots, whereas monoclonal antibodies directed against the neuronal NOS gave specific products. These findings suggest that human aortic SMC express a constitutive neuronal NOS isoform, the enzymatic activity of which is modulated by flow.
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
August 1995,
Biochemical and biophysical research communications,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
February 1996,
European journal of pharmacology,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
January 1990,
Clinical and experimental hypertension. Part A, Theory and practice,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
June 2000,
Prostaglandins, leukotrienes, and essential fatty acids,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
July 1996,
British journal of pharmacology,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
January 1996,
Heart and vessels,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
August 1999,
Biochemical and biophysical research communications,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
March 2000,
Biochemical pharmacology,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
March 1997,
Biochemical and biophysical research communications,
M Papadaki, and
R G Tilton, and
S G Eskin, and
L V McIntire
February 2000,
Arteriosclerosis, thrombosis, and vascular biology,
